Submission Details
| 510(k) Number | K243405 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 01, 2024 |
| Decision Date | November 21, 2024 |
| Days to Decision | 20 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K243405 is an FDA 510(k) clearance for the Xpert vanA, a System, Test, Genotypic Detection, Resistant Markers, Enterococcus Species (Class II — Special Controls, product code NIJ), submitted by Cepheid (Sunnyvale, US). The FDA issued a Cleared decision on November 21, 2024, 20 days after receiving the submission on November 1, 2024. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.1640.
| 510(k) Number | K243405 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 01, 2024 |
| Decision Date | November 21, 2024 |
| Days to Decision | 20 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | NIJ — System, Test, Genotypic Detection, Resistant Markers, Enterococcus Species |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.1640 |
| Definition | The In Vitro Device Is Intended To Detect The Presence Of The Vana And Vanb Genes In Isolated Colonies Of Enterococcus Spp. As A Marker For Vancomycin Resistance Using Dna Probe Technology |